Navigation Links
Prolifiq and viaLanguage Announce Partnership: Accelerate the Use of Localized Content by Sales Teams

PORTLAND, Ore., Feb. 8 /PRNewswire/ -- Prolifiq and viaLanguage today announced a partnership to enhance the use of localized content by sales teams. Together, the companies will offer a combined solution that reduces the time for translated content to reach the hands of global sales professionals and provide critical measurements of how localized assets accelerate the sales cycle. This combination gives the sales person the right information, individualized, to meet the needs and language of their clients and prospects.

Access to quality, up-to-date localized content is often burdensome and costly for companies. By reducing the cycle of time from content creation to content distribution, Prolifiq and viaLanguage will help businesses get to market faster and remain competitive. In addition, Prolifiq's Content Performance Index (CPI) provides companies with the data to know which translated content resonates with local sales teams and customers. Combining viaLanguage's Online Language System (OLS) enables fast turn around and skilled translations for each solution needed.

"Content sells, and with this partnership we now make it faster and easier for our Technology and Life Sciences customers to provide localized content to their global sales teams," said Jeff Gaus, CEO of Prolifiq. "And with CPI, they can maximize their investment and get localized content utilizing viaLanguage's experience by seeing, in real-time, what content their customers find most valuable."

"Working with Prolifiq will not only reduce the time it takes translated content to reach the field, but will allow us to provide to our customers critical visibility into the impact of our localized content on the sales process," said Chanin Ballance, CEO of viaLanguage. "Our set of online translation and localization services is geared to today's fast-paced, cross-cultural business environment, and the integrated workflow with Prolifiq is a natural extension of these services."

About Prolifiq

Prolifiq helps sales professionals use digital content in their communications with customers and prospects. Used in highly regulated environments such as Life Sciences and competitive industries such as Technology, Prolifiq's messaging solutions help sellers match approved content to their selling conversation, wrap it in branded messages and measure the effectiveness of their communications. Customers include: AtriCure, Cisco Systems, GE, The BBC, Associated Press, and Getty Images. For more information, visit

About viaLanguage

viaLanguage is a leading provider of online language translation and localization services. Through the unique combination of its Online Language System (OLS), expert linguists and integration capabilities, viaLanguage offers organizations a comprehensive, affordable solution for meeting today's increasing need for effective multilingual communications. viaLanguage services are designed to help clients quickly and easily develop the very best multilingual websites, software applications, marketing materials and other global communications. Since 2000, the company has earned a reputation among its clients for reliability, quality and professionalism. Clients include: Blue Shield California, Regence, A-dec, Disney, BASF, Nike, and Citibank, as well as many hospitals, school districts and state governments. Corporate Headquarters are located at 700 SW Taylor Street, Suite 310, Portland, OR 97205.  For more information, visit or call us at 503-243-2007.

Legal Notice: All rights reserved. Prolifiq is either a trademark or registered trademark and the Prolifiq logo is a trademark of Prolifiq Software, Inc. Product specifications are subject to change without notice.

SOURCE Prolifiq



SOURCE Prolifiq
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Prolifiq and EthicsPoint Announce Partnership: Automatic Alerts Help Life Sciences Engage in Good Promotional Practices
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):